| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 09/08/2012 | 14h24 | Dow Jones News | AstraZeneca: Bristol-Myers Squibb Completes Purchase of Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/08/2012 | 22h11 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/08/2012 | 15h19 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/08/2012 | 14h40 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/08/2012 | 22h26 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/08/2012 | 00h03 | Dow Jones News | 2nd UPDATE: Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/08/2012 | 20h00 | Dow Jones News | UPDATE: Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/08/2012 | 18h30 | Dow Jones News | Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/08/2012 | 18h17 | Dow Jones News | U.S. Charges Bristol-Myers Executive With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/08/2012 | 17h07 | Dow Jones News | Bristol-Myers Pension Executive Robert Ramnarine Arrested for Alleged Insider Trading -Bloomberg | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/08/2012 | 14h15 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/08/2012 | 13h49 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/08/2012 | 13h30 | Business Wire | Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 31/07/2012 | 19h32 | Zacks | Solid Quarter at ALKS, View Backed - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 30/07/2012 | 22h23 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 23h22 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 23h13 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 23h10 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 02h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 02h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 02h07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 02h07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 02h07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 02h06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 27/07/2012 | 02h06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 26/07/2012 | 16h24 | Dow Jones News | Evercore 2nd-Quarter Profit Climbs 19% On Higher Investment Banking Revenue | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 25/07/2012 | 14h20 | Dow Jones News | Bristol-Myers Profit Falls 28% | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 25/07/2012 | 14h00 | Dow Jones News | Bristol-Myers 2nd-Quarter Profit Falls 28% on Drug-Patent Expirations | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 25/07/2012 | 11h39 | Zacks | Generic Plavix Hurts Bristol-Myers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 25/07/2012 | 11h39 | Zacks | Generic Plavix Hurts Bristol-Myers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |